|
|
|
|
|
| (11) | Liudijimo numeris | C 3052628 |
| (68) | Patento numeris | 3052628 |
| (21) | Paraiškos papildomos apsaugos liudijimui gauti numeris | PA 2020 527 |
| (22) | Paraiškos papildomos apsaugos liudijimui gauti padavimo data | 2020-08-26 |
| (41) | Paraiškos papildomos apsaugos liudijimui gauti paskelbimo data | 2020-09-25 |
| Liudijimo paskelbimo data | 2022-04-11 | |
| (24) | Liudijimo įsigaliojimo data | 2034-10-04 |
| (71) |
Alnylam Pharmaceuticals, Inc.,
300 Third Street, Cambridge, MA 02142,
US
Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, US |
| (73) |
Alnylam Pharmaceuticals, Inc.,
300 Third Street, Cambridge, MA 02142,
US
Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, US |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (93) | EU/1/20/1428, 2020-03-02 |
| (94) | 2035-03-04 |
| (95) | Givosiranas arba jo farmaciniu požiūriu priimtina druska |
| PAL išduotas |